Exagen Current Deferred Revenue (Quarterly) Analysis

Exagen, Inc. (XGN)

6.08 +0.07 (+1.16%) USD | NASDAQ | Dec 31, 16:00

6.10 +0.02 (+0.33%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for XGN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

FONAR Corp.	Upgrade
XWELL, Inc.	Upgrade
ProPhase Labs, Inc.	Upgrade
Veracyte, Inc.	Upgrade
Insight Molecular Diagnostics, Inc.	--